We are live on
!
Find out more
QF
QVT Financial Portfolio holdings
AUM
$1.37B
1-Year Est. Return
148.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$953M
AUM Growth
-$819M
(-46%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-127.13%
Top 10 Holdings %
Top 10 Hldgs %
71.93%
Holding
67
New
7
Increased
8
Reduced
17
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$38.3M |
| 2 |
GNRT
Gener8 Maritime, Inc.
GNRT
|
+$17.7M |
| 3 |
FTSI
FTS International, Inc. Common Stock
FTSI
|
+$15.6M |
| 4 |
GDS Holdings
GDS
|
+$15.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$471M |
| 2 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$395M |
| 3 |
Arbutus Biopharma
ABUS
|
+$80.9M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$20.9M |
| 5 |
Goldman Sachs
GS
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.32% |
| 2 | Consumer Discretionary | 6.23% |
| 3 | Communication Services | 5.77% |
| 4 | Energy | 4% |
| 5 | Technology | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $174M | 18.26% |
1,984,100
+489,100
| +33% | +$44.7M |
|
|
2
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $66.4M | 6.97% |
757,067
+419,500
| +124% | +$38.3M |
|
3
MakeMyTrip
MMYT
$4.67B
| $39.8M | 4.17% |
1,200,001
-216,840
| -15% | -$6.91M |
|
|
KANG
4
DELISTED
iKang Healthcare Group, Inc.
KANG
| $23M | 2.41% |
1,151,464
+200,000
| +21% | +$3.36M |
|
5
Iovance Biotherapeutics
IOVA
$2.23B
| $22.5M | 2.36% |
1,411,695
+287,400
| +26% | +$4.35M |
|
|
GNRT
6
DELISTED
Gener8 Maritime, Inc.
GNRT
| $19.6M | 2.05% |
3,637,189
+2,976,249
| +450% | +$17.7M |
|
|
7
GDS Holdings
GDS
$6.34B
| $14.9M | 1.57% |
+573,736
| New | +$15.1M |
|
|
FTSI
8
DELISTED
FTS International, Inc. Common Stock
FTSI
| $14.8M | 1.55% |
+40,219
| New | +$15.6M |
|
|
XLRN
9
DELISTED
Acceleron Pharma
XLRN
| $14.1M | 1.48% |
373,481
| – | – |
|
|
AGEN
10
Agenus
AGEN
$249M
| $13.2M | 1.38% |
152,638
-10,466
| -6% | -$930K |
|
11
Anterix
ATEX
$1.83B
| $11.9M | 1.25% |
514,396
-1,878
| -0.4% | -$62.8K |
|
12
New York Times
NYT
$11.6B
| $11.3M | 1.18% |
466,889
-300,000
| -39% | -$6.89M |
|
|
NRE
13
DELISTED
NorthStar Realty Europe Corp.
NRE
| $11.2M | 1.17% |
891,000
| – | – |
|
14
Home Depot
HD
$332B
| $10.2M | 1.07% |
57,357
| – | – |
|
|
15
Meta Platforms (Facebook)
META
$1.51T
| $9.76M | 1.02% |
+61,100
| New | +$11M |
|
|
HUNT
16
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
| $9.75M | 1.02% |
1,000,000
| – | – |
|
|
TRCO
17
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $9.54M | 1% |
235,600
+160,056
| +212% | +$6.75M |
|
18
CarMax
KMX
$8.27B
| $9.37M | 0.98% |
151,253
| – | – |
|
19
JPMorgan Chase
JPM
$939B
| $8.34M | 0.87% |
75,849
| – | – |
|
|
ADAP
20
DELISTED
Adaptimmune Therapeutics
ADAP
| $7.83M | 0.82% |
731,510
-122,375
| -14% | -$1.07M |
|
21
argenx
ARGX
$57.4B
| $7.3M | 0.77% |
93,034
-86,526
| -48% | -$6.53M |
|
|
NEX
22
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $7.08M | 0.74% |
478,695
+138,773
| +41% | +$2.27M |
|
|
AVXS
23
DELISTED
AveXis, Inc. Common Stock
AVXS
| $6.16M | 0.65% |
49,823
| – | – |
|
24
Patterson-UTI
PTEN
$3.87B
| $5.27M | 0.55% |
300,933
+9,833
| +3% | +$205K |
|
25
Wells Fargo
WFC
$261B
| $5.15M | 0.54% |
98,300
| – | – |
|
Similar funds
KRS
AF
PGP
DC
FC
PP
MAWA
SOS
QVT Financial's Q1 2018 Portfolio in Review
As of Q1 2018, QVT Financial held 67 positions worth $953M, down 46% from $1.77B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
QVT Financial withdrew a net $1.21B in Q1 2018, closing 14 positions and reducing 17 holdings. Its most notable exit was Myovant Sciences Ltd., an estimated $471M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, QVT Financial opened a new position in FTS International, Inc. Common Stock worth $14.8M.
- QVT Financial's largest Q1 2018 buy was FTS International, Inc. Common Stock: 40,219 shares worth $14.8M.
- QVT Financial added most to State Street SPDR S&P Biotech ETF in Q1 2018, an estimated $38.3M increase.
- QVT Financial's biggest Q1 2018 reduction was MakeMyTrip, cutting an estimated $6.91M.
- QVT Financial fully exited Myovant Sciences Ltd. in Q1 2018, selling an estimated $471M.
- QVT Financial's ten largest holdings make up 72% of its $953M portfolio in Q1 2018.
- QVT Financial opened 7 new positions and closed 14 in Q1 2018.
- QVT Financial's portfolio value fell 46% quarter-over-quarter to $953M.
Based on QVT Financial's 13F filing for Q1 2018, filed 15 May 2018.